Envision Pharma Group - About the company
Envision Pharma Group is an acquired company based in Horsham (United Kingdom), founded in 2001. It operates as a Technology-enabled strategic solutions partner for life sciences, driving improved patient outcomes. The company has 991 active competitors, including 112 funded and 70 that have exited. Its top competitors include companies like Verily, Truveta and Carta Healthcare.
Company Details
Technology-enabled strategic solutions partner for life sciences, driving improved patient outcomes. The company provides comprehensive services and technology solutions, including artificial intelligence and natural language processing, to support clients across the product lifecycle. Services include commercialization and integrated strategic consulting, evidence-based scientific communications and engagement, HEOR/market access and data analytics, medical capabilities, and omnichannel solutions. The company offers SaaS platforms, workflow platforms, and benchmarking software. It leverages technology, data, and artificial intelligence to accelerate decision-making and improve compliance. The company focuses on medical affairs, medical communications, publication management, medical education, and MSL engagement. It provides solutions for life sciences teams, including strategic consulting, value and access, and commercialization. The company's offerings include AI-powered insights, data analytics, and technology-enabled strategic solutions.
- Website
- envisionpharmagroup.com
- Registered Address
- Fairfield, Connecticut
Key Metrics
Founded Year
2001
Location
Horsham, United Kingdom
Stage
Acquired
Investors
Ranked
20th among 991 active competitors
Employee Count
1,023 as on Sep 30, 2026
Exit Details
Acquired by GHO Capital Partners (Jul 06, 2016)
Legal entities associated with Envision Pharma Group
Envision Pharma Group is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
ENVISION PHARMA LIMITED CIN: 4486293 , United Kingdom, Active | Jul 14, 2002 | $10M - $50M (As on Dec 31, 2025) | - | |
ENVISION PHARMA GROUP LIMITED CIN: 10117262 , United Kingdom, Active | Apr 10, 2016 | £0 - £1M (As on Dec 31, 2024) | - | |
ENVISION PHARMA, INC. CIN: 61633253 , United States, Active | Dec 26, 999 | - | 758 (As on Dec 31, 2024) | - |
Envision Pharma Group's acquisition details
Envision Pharma Group got acquired by GHO Capital Partners and Ardian on Jul 06, 2016.
Click here to take a look at Envision Pharma Group's acquisition in detail
Sign up to download Envision Pharma Group's company profile
Envision Pharma Group's funding and investors
Envision Pharma Group is a funded company. Envision Pharma Group has 5 institutional investors.
View details of Envision Pharma Group's funding rounds and investors
Envision Pharma Group's founders and board of directors
Founder? Claim ProfileEnvision Pharma Group's employee count trend
Envision Pharma Group has 1,023 employees as of Sep 26. Here is Envision Pharma Group's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Envision Pharma Group's Competitors and alternates
Top competitors of Envision Pharma Group include Verily, Truveta and Carta Healthcare. Here is the list of Top 10 competitors of Envision Pharma Group, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 78/100 | |
2nd | Truveta 2020, Seattle (United States), Series C | Provider of healthcare data platform for learning services | $515M | 68/100 | |
3rd | Carta Healthcare 2017, San Mateo (United States), Series B | Provider of an AI platform for clinical data management solutions | $80.6M | 66/100 | |
4th | Abacus Insights 2017, New York City (United States), Series C | Provider of data management solutions | $94.9M | 65/100 | |
5th | MediSpend 1999, Portsmouth (United States), Acquired | Compliance management software for spend analytics in life sciences industry | - | 64/100 | |
6th | Mighty 2015, New York City (United States), Series B | Provider of software solutions for the management of legal funding | $14.2M | 64/100 | |
7th | Motivity 2002, Seattle (United States), Series A | Provider of software for collecting data for clinics | $38M | 62/100 | |
8th | Provider of artificial intelligence software for global regulatory compliance management | $10M | 61/100 | ||
9th | Kneat Solutions 2006, Limerick (Ireland), Acquired | Software platform for electronic validation life cycle | $6.11M | 61/100 | |
10th | MetricStream 1999, San Jose (United States), Series D | Developer of software for governance risk and compliance management processes | $213M | 60/100 | |
20th | Envision Pharma Group 2001, Horsham (United Kingdom), Acquired | Technology-enabled strategic solutions partner for life sciences, driving improved patient outcomes | - | 55/100 |
Looking for more details on Envision Pharma Group's competitors? Click here to see the top ones
Envision Pharma Group's Investments and acquisitions
Envision Pharma Group has not made any investments yet. Envision Pharma Group has made 6 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Feb 07, 2023 | Acquisition | 2016 | Cambridge (United Kingdom) | |
Mar 19, 2021 | Acquisition | 2014 | Boston (United States) | |
Nov 12, 2020 | Acquisition | 2003 | Powell (United States) |
See all acquisitions by Envision Pharma Group
Reports related to Envision Pharma Group
Here is the latest report on Envision Pharma Group's sector:
News related to Envision Pharma Group
Media has covered Envision Pharma Group for a total of 4 events in the last 1 year, 2 of them have been about people movement and 1 about company updates.
•
Envision Pharma Group Appoints Leigh Anne Siino as Senior Vice President of Commercial, Two Labs and RiparianNewswire•Nov 10, 2026•Envision Pharma Group
•
Envision Pharma Group Names Ryan Tubbs Senior Vice President, Commercial GrowthNewswire•Aug 25, 2026•Envision Pharma Group
•
Envision Pharma Group Promotes Jennifer Lospinoso to President of RiparianNewswire•Jun 25, 2026•Envision Pharma Group
•
Envision Pharma Group appoints Nick Jones as President, Envision Medical CommunicationsAccess Newswire•Apr 08, 2026•Envision Pharma Group
•
Envision Pharma Group Appoints Tom Langan as Chief Executive OfficerGlobeNewswire•Aug 05, 2025•Envision Pharma Group
•
Immedica Successfully Completes Tender Offer For All Outstanding Shares Of Common Stock Of Marinus Pharmaceuticals, Inc.Cision•Feb 07, 2025•Immedica, Marinus Pharma, Envision Pharma Group
•
•
Envision Pharma Group Announces the Appointment of Bill Shirey to President of Life Science CommercializationNewswire•Jul 30, 2024•Envision Pharma Group, CuraScript SD
•
Envision Pharma Group Announces The Appointment Of Alistair Macdonald To Board Of DirectorsNewswire•May 08, 2024•Envision Pharma Group
•
Two Labs Unveils Service for Pharma Compliance and Transparency ReportingBNN•Feb 07, 2024•Two Labs, Envision Pharma Group
Are you a Founder ?
FAQs about Envision Pharma Group
Explore our recently published companies
- Lacy And Par - Tukwila based, 1984 founded, Unfunded company
- Moeheat - Santa Clarita based, 2008 founded, Public company
- Z-axis Prints - Spokane based, 2010 founded, Unfunded company
- Zen Creative Group - Portland based, 1995 founded, Unfunded company
- Rjo Ventures - North Miami Beach based, 2011 founded, Unfunded company
- Roberts Design - Las Vegas based, 2014 founded, Unfunded company